nodes	percent_of_prediction	percent_of_DWPC	metapath
Calcipotriol—MPO—hematologic cancer	0.579	1	CbGaD
Calcipotriol—MPO—Cisplatin—hematologic cancer	0.0558	1	CbGbCtD
Calcipotriol—CYP24A1—hematopoietic system—hematologic cancer	0.0068	0.183	CbGeAlD
Calcipotriol—CYP24A1—lung—hematologic cancer	0.00395	0.106	CbGeAlD
Calcipotriol—VDR—hematopoietic system—hematologic cancer	0.00374	0.101	CbGeAlD
Calcipotriol—MPO—hematopoietic system—hematologic cancer	0.00316	0.0849	CbGeAlD
Calcipotriol—VDR—blood—hematologic cancer	0.00248	0.0667	CbGeAlD
Calcipotriol—VDR—bone marrow—hematologic cancer	0.0024	0.0646	CbGeAlD
Calcipotriol—VDR—lung—hematologic cancer	0.00217	0.0585	CbGeAlD
Calcipotriol—MPO—blood—hematologic cancer	0.00209	0.0563	CbGeAlD
Calcipotriol—VDR—testis—hematologic cancer	0.00205	0.0552	CbGeAlD
Calcipotriol—MPO—bone marrow—hematologic cancer	0.00202	0.0545	CbGeAlD
Calcipotriol—MPO—lung—hematologic cancer	0.00183	0.0493	CbGeAlD
Calcipotriol—MPO—testis—hematologic cancer	0.00173	0.0466	CbGeAlD
Calcipotriol—VDR—lymph node—hematologic cancer	0.00149	0.04	CbGeAlD
Calcipotriol—MPO—lymph node—hematologic cancer	0.00125	0.0337	CbGeAlD
Calcipotriol—VDR—Regulation of nuclear SMAD2/3 signaling—HDAC2—hematologic cancer	0.00043	0.00327	CbGpPWpGaD
Calcipotriol—VDR—Direct p53 effectors—TNFRSF10B—hematologic cancer	0.000426	0.00323	CbGpPWpGaD
Calcipotriol—CYP24A1—Metapathway biotransformation—GSTO1—hematologic cancer	0.000425	0.00323	CbGpPWpGaD
Calcipotriol—MPO—Folate Metabolism—SOD2—hematologic cancer	0.000421	0.00319	CbGpPWpGaD
Calcipotriol—MPO—IL23-mediated signaling events—PIK3R1—hematologic cancer	0.00041	0.00312	CbGpPWpGaD
Calcipotriol—MPO—Folate Metabolism—IL4—hematologic cancer	0.000408	0.00309	CbGpPWpGaD
Calcipotriol—CYP24A1—Biological oxidations—UGT1A1—hematologic cancer	0.000405	0.00308	CbGpPWpGaD
Calcipotriol—VDR—Validated transcriptional targets of TAp63 isoforms—FAS—hematologic cancer	0.000404	0.00307	CbGpPWpGaD
Calcipotriol—CYP24A1—Metapathway biotransformation—UGT1A1—hematologic cancer	0.0004	0.00304	CbGpPWpGaD
Calcipotriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—ATM—hematologic cancer	0.000399	0.00303	CbGpPWpGaD
Calcipotriol—MPO—IL23-mediated signaling events—JAK2—hematologic cancer	0.000399	0.00303	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	0.000399	0.00303	CbGpPWpGaD
Calcipotriol—MPO—Vitamin B12 Metabolism—ICAM1—hematologic cancer	0.000398	0.00302	CbGpPWpGaD
Calcipotriol—Erythema—Hydroxyurea—hematologic cancer	0.000393	0.002	CcSEcCtD
Calcipotriol—MPO—IL23-mediated signaling events—IFNG—hematologic cancer	0.000392	0.00297	CbGpPWpGaD
Calcipotriol—Stinging—Epirubicin—hematologic cancer	0.000389	0.00198	CcSEcCtD
Calcipotriol—Skin exfoliation—Prednisone—hematologic cancer	0.000384	0.00196	CcSEcCtD
Calcipotriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—hematologic cancer	0.000383	0.0029	CbGpPWpGaD
Calcipotriol—Hypersensitivity—Methoxsalen—hematologic cancer	0.000379	0.00193	CcSEcCtD
Calcipotriol—MPO—IL23-mediated signaling events—CD4—hematologic cancer	0.000378	0.00287	CbGpPWpGaD
Calcipotriol—MPO—C-MYB transcription factor network—KITLG—hematologic cancer	0.000376	0.00285	CbGpPWpGaD
Calcipotriol—VDR—Regulation of nuclear SMAD2/3 signaling—AR—hematologic cancer	0.000373	0.00283	CbGpPWpGaD
Calcipotriol—Paraesthesia—Procarbazine—hematologic cancer	0.000372	0.00189	CcSEcCtD
Calcipotriol—VDR—Nuclear Receptor transcription pathway—ESR1—hematologic cancer	0.000371	0.00281	CbGpPWpGaD
Calcipotriol—VDR—Direct p53 effectors—DKK1—hematologic cancer	0.000371	0.00281	CbGpPWpGaD
Calcipotriol—MPO—Folate Metabolism—MTHFR—hematologic cancer	0.00037	0.00281	CbGpPWpGaD
Calcipotriol—Dry skin—Prednisolone—hematologic cancer	0.000369	0.00188	CcSEcCtD
Calcipotriol—Hypersensitivity—Mercaptopurine—hematologic cancer	0.000369	0.00188	CcSEcCtD
Calcipotriol—Erythema—Bortezomib—hematologic cancer	0.000367	0.00187	CcSEcCtD
Calcipotriol—VDR—Ovarian Infertility Genes—CDKN1B—hematologic cancer	0.000366	0.00278	CbGpPWpGaD
Calcipotriol—Pain—Busulfan—hematologic cancer	0.000365	0.00186	CcSEcCtD
Calcipotriol—Paraesthesia—Bexarotene—hematologic cancer	0.000365	0.00186	CcSEcCtD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	0.000365	0.00277	CbGpPWpGaD
Calcipotriol—Pruritus—Methoxsalen—hematologic cancer	0.000364	0.00185	CcSEcCtD
Calcipotriol—Erythema—Bleomycin—hematologic cancer	0.000364	0.00185	CcSEcCtD
Calcipotriol—Paraesthesia—Fludarabine—hematologic cancer	0.000364	0.00185	CcSEcCtD
Calcipotriol—Hypersensitivity—Daunorubicin—hematologic cancer	0.000364	0.00185	CcSEcCtD
Calcipotriol—Hypersensitivity—Clofarabine—hematologic cancer	0.000364	0.00185	CcSEcCtD
Calcipotriol—Hypersensitivity—Pentostatin—hematologic cancer	0.000362	0.00184	CcSEcCtD
Calcipotriol—Stinging—Doxorubicin—hematologic cancer	0.00036	0.00183	CcSEcCtD
Calcipotriol—Erythema—Vinorelbine—hematologic cancer	0.000358	0.00182	CcSEcCtD
Calcipotriol—MPO—Vitamin B12 Metabolism—CCL2—hematologic cancer	0.000356	0.0027	CbGpPWpGaD
Calcipotriol—Pain—Procarbazine—hematologic cancer	0.000354	0.0018	CcSEcCtD
Calcipotriol—MPO—Folate Metabolism—CRP—hematologic cancer	0.000352	0.00267	CbGpPWpGaD
Calcipotriol—CYP24A1—Biological oxidations—MTR—hematologic cancer	0.000352	0.00267	CbGpPWpGaD
Calcipotriol—MPO—IL23-mediated signaling events—IL1B—hematologic cancer	0.000349	0.00265	CbGpPWpGaD
Calcipotriol—Pruritus—Clofarabine—hematologic cancer	0.000349	0.00178	CcSEcCtD
Calcipotriol—Pruritus—Daunorubicin—hematologic cancer	0.000349	0.00178	CcSEcCtD
Calcipotriol—Hypersensitivity—Idarubicin—hematologic cancer	0.000349	0.00178	CcSEcCtD
Calcipotriol—MPO—IL23-mediated signaling events—IL2—hematologic cancer	0.000348	0.00264	CbGpPWpGaD
Calcipotriol—MPO—C-MYB transcription factor network—HES1—hematologic cancer	0.000348	0.00264	CbGpPWpGaD
Calcipotriol—Pruritus—Pentostatin—hematologic cancer	0.000348	0.00177	CcSEcCtD
Calcipotriol—Pruritus—Anagrelide—hematologic cancer	0.000348	0.00177	CcSEcCtD
Calcipotriol—Pain—Bexarotene—hematologic cancer	0.000347	0.00177	CcSEcCtD
Calcipotriol—Pain—Dasatinib—hematologic cancer	0.000347	0.00177	CcSEcCtD
Calcipotriol—VDR—Retinoic acid receptors-mediated signaling—MAPK8—hematologic cancer	0.000347	0.00263	CbGpPWpGaD
Calcipotriol—Pain—Fludarabine—hematologic cancer	0.000346	0.00176	CcSEcCtD
Calcipotriol—MPO—C-MYB transcription factor network—NCOR1—hematologic cancer	0.000346	0.00262	CbGpPWpGaD
Calcipotriol—MPO—C-MYB transcription factor network—GSTM1—hematologic cancer	0.000346	0.00262	CbGpPWpGaD
Calcipotriol—VDR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—hematologic cancer	0.000344	0.00261	CbGpPWpGaD
Calcipotriol—Erythema—Thiotepa—hematologic cancer	0.000342	0.00174	CcSEcCtD
Calcipotriol—Hypersensitivity—Teniposide—hematologic cancer	0.00034	0.00173	CcSEcCtD
Calcipotriol—VDR—Direct p53 effectors—PML—hematologic cancer	0.000338	0.00257	CbGpPWpGaD
Calcipotriol—VDR—Direct p53 effectors—SMARCA4—hematologic cancer	0.000338	0.00257	CbGpPWpGaD
Calcipotriol—VDR—Retinoic acid receptors-mediated signaling—EP300—hematologic cancer	0.000338	0.00257	CbGpPWpGaD
Calcipotriol—Paraesthesia—Nilotinib—hematologic cancer	0.000337	0.00171	CcSEcCtD
Calcipotriol—Paraesthesia—Imatinib—hematologic cancer	0.000335	0.0017	CcSEcCtD
Calcipotriol—CYP24A1—Biological oxidations—GSTT1—hematologic cancer	0.000334	0.00254	CbGpPWpGaD
Calcipotriol—MPO—Selenium Micronutrient Network—SOD2—hematologic cancer	0.000334	0.00254	CbGpPWpGaD
Calcipotriol—MPO—Vitamin B12 Metabolism—ALB—hematologic cancer	0.000332	0.00252	CbGpPWpGaD
Calcipotriol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—hematologic cancer	0.00033	0.0025	CbGpPWpGaD
Calcipotriol—Paraesthesia—Cladribine—hematologic cancer	0.000329	0.00167	CcSEcCtD
Calcipotriol—Pain—Chlorambucil—hematologic cancer	0.000328	0.00167	CcSEcCtD
Calcipotriol—VDR—Direct p53 effectors—MLH1—hematologic cancer	0.000327	0.00248	CbGpPWpGaD
Calcipotriol—Pruritus—Teniposide—hematologic cancer	0.000326	0.00166	CcSEcCtD
Calcipotriol—VDR—Regulation of nuclear SMAD2/3 signaling—IL10—hematologic cancer	0.000326	0.00247	CbGpPWpGaD
Calcipotriol—VDR—Regulation of nuclear SMAD2/3 signaling—NCOR1—hematologic cancer	0.000326	0.00247	CbGpPWpGaD
Calcipotriol—Rash—Methoxsalen—hematologic cancer	0.000325	0.00165	CcSEcCtD
Calcipotriol—Dermatitis—Methoxsalen—hematologic cancer	0.000324	0.00165	CcSEcCtD
Calcipotriol—MPO—Folate Metabolism—ICAM1—hematologic cancer	0.000324	0.00246	CbGpPWpGaD
Calcipotriol—Skin exfoliation—Methotrexate—hematologic cancer	0.000321	0.00163	CcSEcCtD
Calcipotriol—Pain—Nilotinib—hematologic cancer	0.000321	0.00163	CcSEcCtD
Calcipotriol—Pain—Imatinib—hematologic cancer	0.000319	0.00162	CcSEcCtD
Calcipotriol—VDR—Regulation of nuclear SMAD2/3 signaling—FOXO1—hematologic cancer	0.000318	0.00241	CbGpPWpGaD
Calcipotriol—Erythema—Carmustine—hematologic cancer	0.000318	0.00162	CcSEcCtD
Calcipotriol—Paraesthesia—Vinblastine—hematologic cancer	0.000316	0.00161	CcSEcCtD
Calcipotriol—Rash—Mercaptopurine—hematologic cancer	0.000315	0.0016	CcSEcCtD
Calcipotriol—Dermatitis—Mercaptopurine—hematologic cancer	0.000315	0.0016	CcSEcCtD
Calcipotriol—Hypersensitivity—Busulfan—hematologic cancer	0.000315	0.0016	CcSEcCtD
Calcipotriol—Erythema—Alitretinoin—hematologic cancer	0.000315	0.0016	CcSEcCtD
Calcipotriol—Pain—Cladribine—hematologic cancer	0.000314	0.00159	CcSEcCtD
Calcipotriol—Rash—Daunorubicin—hematologic cancer	0.000311	0.00158	CcSEcCtD
Calcipotriol—Rash—Clofarabine—hematologic cancer	0.000311	0.00158	CcSEcCtD
Calcipotriol—Erythema—Ifosfamide—hematologic cancer	0.000311	0.00158	CcSEcCtD
Calcipotriol—Dermatitis—Daunorubicin—hematologic cancer	0.000311	0.00158	CcSEcCtD
Calcipotriol—Dermatitis—Clofarabine—hematologic cancer	0.000311	0.00158	CcSEcCtD
Calcipotriol—Rash—Anagrelide—hematologic cancer	0.00031	0.00158	CcSEcCtD
Calcipotriol—Rash—Pentostatin—hematologic cancer	0.00031	0.00158	CcSEcCtD
Calcipotriol—Dermatitis—Pentostatin—hematologic cancer	0.000309	0.00157	CcSEcCtD
Calcipotriol—Dermatitis—Anagrelide—hematologic cancer	0.000309	0.00157	CcSEcCtD
Calcipotriol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TNF—hematologic cancer	0.000308	0.00234	CbGpPWpGaD
Calcipotriol—Dry skin—Dexamethasone—hematologic cancer	0.000308	0.00157	CcSEcCtD
Calcipotriol—Dry skin—Betamethasone—hematologic cancer	0.000308	0.00157	CcSEcCtD
Calcipotriol—Hypersensitivity—Procarbazine—hematologic cancer	0.000305	0.00155	CcSEcCtD
Calcipotriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—hematologic cancer	0.000304	0.00231	CbGpPWpGaD
Calcipotriol—VDR—Retinoic acid receptors-mediated signaling—MAPK3—hematologic cancer	0.000303	0.0023	CbGpPWpGaD
Calcipotriol—MPO—Vitamin B12 Metabolism—IFNG—hematologic cancer	0.000303	0.0023	CbGpPWpGaD
Calcipotriol—Pruritus—Busulfan—hematologic cancer	0.000302	0.00154	CcSEcCtD
Calcipotriol—VDR—Regulation of nuclear SMAD2/3 signaling—NR3C1—hematologic cancer	0.000302	0.00229	CbGpPWpGaD
Calcipotriol—Pain—Vinblastine—hematologic cancer	0.000301	0.00153	CcSEcCtD
Calcipotriol—Skin exfoliation—Epirubicin—hematologic cancer	0.000301	0.00153	CcSEcCtD
Calcipotriol—Paraesthesia—Melphalan—hematologic cancer	0.0003	0.00153	CcSEcCtD
Calcipotriol—Hypersensitivity—Bexarotene—hematologic cancer	0.000299	0.00152	CcSEcCtD
Calcipotriol—Hypersensitivity—Dasatinib—hematologic cancer	0.000299	0.00152	CcSEcCtD
Calcipotriol—Rash—Idarubicin—hematologic cancer	0.000299	0.00152	CcSEcCtD
Calcipotriol—Dermatitis—Idarubicin—hematologic cancer	0.000298	0.00152	CcSEcCtD
Calcipotriol—Hypersensitivity—Fludarabine—hematologic cancer	0.000298	0.00152	CcSEcCtD
Calcipotriol—Erythema—Mitoxantrone—hematologic cancer	0.000295	0.0015	CcSEcCtD
Calcipotriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—MDM2—hematologic cancer	0.000295	0.00224	CbGpPWpGaD
Calcipotriol—MPO—Selenium Micronutrient Network—MTHFR—hematologic cancer	0.000294	0.00223	CbGpPWpGaD
Calcipotriol—Pruritus—Procarbazine—hematologic cancer	0.000293	0.00149	CcSEcCtD
Calcipotriol—MPO—IL23-mediated signaling events—STAT3—hematologic cancer	0.000293	0.00222	CbGpPWpGaD
Calcipotriol—Paraesthesia—Lenalidomide—hematologic cancer	0.000292	0.00149	CcSEcCtD
Calcipotriol—Rash—Teniposide—hematologic cancer	0.000291	0.00148	CcSEcCtD
Calcipotriol—Dermatitis—Teniposide—hematologic cancer	0.00029	0.00148	CcSEcCtD
Calcipotriol—MPO—Folate Metabolism—CCL2—hematologic cancer	0.00029	0.0022	CbGpPWpGaD
Calcipotriol—Erythema—Gemcitabine—hematologic cancer	0.000288	0.00146	CcSEcCtD
Calcipotriol—Pruritus—Dasatinib—hematologic cancer	0.000287	0.00146	CcSEcCtD
Calcipotriol—Pruritus—Bexarotene—hematologic cancer	0.000287	0.00146	CcSEcCtD
Calcipotriol—Pruritus—Fludarabine—hematologic cancer	0.000287	0.00146	CcSEcCtD
Calcipotriol—Pain—Melphalan—hematologic cancer	0.000286	0.00146	CcSEcCtD
Calcipotriol—Hypersensitivity—Chlorambucil—hematologic cancer	0.000283	0.00144	CcSEcCtD
Calcipotriol—MPO—Selenium Micronutrient Network—CRP—hematologic cancer	0.00028	0.00212	CbGpPWpGaD
Calcipotriol—Skin exfoliation—Doxorubicin—hematologic cancer	0.000278	0.00142	CcSEcCtD
Calcipotriol—Pain—Lenalidomide—hematologic cancer	0.000278	0.00141	CcSEcCtD
Calcipotriol—VDR—Direct p53 effectors—HDAC2—hematologic cancer	0.000278	0.00211	CbGpPWpGaD
Calcipotriol—Hypersensitivity—Nilotinib—hematologic cancer	0.000276	0.00141	CcSEcCtD
Calcipotriol—Hypersensitivity—Imatinib—hematologic cancer	0.000275	0.0014	CcSEcCtD
Calcipotriol—Pain—Hydroxyurea—hematologic cancer	0.000274	0.00139	CcSEcCtD
Calcipotriol—VDR—Regulation of nuclear SMAD2/3 signaling—CDK2—hematologic cancer	0.000272	0.00207	CbGpPWpGaD
Calcipotriol—VDR—Validated transcriptional targets of TAp63 isoforms—CDKN2A—hematologic cancer	0.000272	0.00206	CbGpPWpGaD
Calcipotriol—Pruritus—Chlorambucil—hematologic cancer	0.000271	0.00138	CcSEcCtD
Calcipotriol—MPO—Vitamin B12 Metabolism—IL1B—hematologic cancer	0.00027	0.00205	CbGpPWpGaD
Calcipotriol—Hypersensitivity—Cladribine—hematologic cancer	0.00027	0.00137	CcSEcCtD
Calcipotriol—MPO—Folate Metabolism—ALB—hematologic cancer	0.00027	0.00205	CbGpPWpGaD
Calcipotriol—Rash—Busulfan—hematologic cancer	0.000269	0.00137	CcSEcCtD
Calcipotriol—Dermatitis—Busulfan—hematologic cancer	0.000269	0.00137	CcSEcCtD
Calcipotriol—Paraesthesia—Bortezomib—hematologic cancer	0.000269	0.00137	CcSEcCtD
Calcipotriol—Erythema—Cisplatin—hematologic cancer	0.000268	0.00136	CcSEcCtD
Calcipotriol—Dry skin—Prednisone—hematologic cancer	0.000268	0.00136	CcSEcCtD
Calcipotriol—Paraesthesia—Bleomycin—hematologic cancer	0.000267	0.00136	CcSEcCtD
Calcipotriol—Pruritus—Nilotinib—hematologic cancer	0.000265	0.00135	CcSEcCtD
Calcipotriol—Pruritus—Imatinib—hematologic cancer	0.000264	0.00134	CcSEcCtD
Calcipotriol—VDR—Validated transcriptional targets of TAp63 isoforms—MDM2—hematologic cancer	0.000264	0.002	CbGpPWpGaD
Calcipotriol—Paraesthesia—Vinorelbine—hematologic cancer	0.000262	0.00133	CcSEcCtD
Calcipotriol—Rash—Procarbazine—hematologic cancer	0.000261	0.00133	CcSEcCtD
Calcipotriol—Dermatitis—Procarbazine—hematologic cancer	0.000261	0.00133	CcSEcCtD
Calcipotriol—Pruritus—Cladribine—hematologic cancer	0.000259	0.00132	CcSEcCtD
Calcipotriol—Hypersensitivity—Vinblastine—hematologic cancer	0.000259	0.00132	CcSEcCtD
Calcipotriol—MPO—Selenium Micronutrient Network—ICAM1—hematologic cancer	0.000257	0.00195	CbGpPWpGaD
Calcipotriol—VDR—Regulation of nuclear SMAD2/3 signaling—CDK4—hematologic cancer	0.000257	0.00195	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	0.000257	0.00195	CbGpPWpGaD
Calcipotriol—MPO—C-MYB transcription factor network—KIT—hematologic cancer	0.000257	0.00195	CbGpPWpGaD
Calcipotriol—Rash—Bexarotene—hematologic cancer	0.000256	0.0013	CcSEcCtD
Calcipotriol—Rash—Dasatinib—hematologic cancer	0.000256	0.0013	CcSEcCtD
Calcipotriol—VDR—Regulation of nuclear SMAD2/3 signaling—ESR1—hematologic cancer	0.000256	0.00194	CbGpPWpGaD
Calcipotriol—Pain—Bortezomib—hematologic cancer	0.000256	0.0013	CcSEcCtD
Calcipotriol—Dermatitis—Dasatinib—hematologic cancer	0.000256	0.0013	CcSEcCtD
Calcipotriol—Dermatitis—Bexarotene—hematologic cancer	0.000256	0.0013	CcSEcCtD
Calcipotriol—Rash—Fludarabine—hematologic cancer	0.000255	0.0013	CcSEcCtD
Calcipotriol—Dermatitis—Fludarabine—hematologic cancer	0.000255	0.0013	CcSEcCtD
Calcipotriol—Pain—Bleomycin—hematologic cancer	0.000254	0.00129	CcSEcCtD
Calcipotriol—MPO—IL23-mediated signaling events—TNF—hematologic cancer	0.000253	0.00192	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—ZNF552—hematologic cancer	0.000253	0.00192	CbGpPWpGaD
Calcipotriol—Paraesthesia—Thiotepa—hematologic cancer	0.000251	0.00127	CcSEcCtD
Calcipotriol—Pain—Vinorelbine—hematologic cancer	0.00025	0.00127	CcSEcCtD
Calcipotriol—MPO—Folate Metabolism—IFNG—hematologic cancer	0.000246	0.00187	CbGpPWpGaD
Calcipotriol—Hypersensitivity—Melphalan—hematologic cancer	0.000246	0.00125	CcSEcCtD
Calcipotriol—Paraesthesia—Thalidomide—hematologic cancer	0.000242	0.00123	CcSEcCtD
Calcipotriol—Erythema—Prednisolone—hematologic cancer	0.000242	0.00123	CcSEcCtD
Calcipotriol—Hypersensitivity—Lenalidomide—hematologic cancer	0.00024	0.00122	CcSEcCtD
Calcipotriol—Pain—Thiotepa—hematologic cancer	0.000239	0.00121	CcSEcCtD
Calcipotriol—MPO—C-MYB transcription factor network—CREBBP—hematologic cancer	0.000238	0.00181	CbGpPWpGaD
Calcipotriol—Pruritus—Melphalan—hematologic cancer	0.000237	0.0012	CcSEcCtD
Calcipotriol—Rash—Nilotinib—hematologic cancer	0.000237	0.0012	CcSEcCtD
Calcipotriol—Dermatitis—Nilotinib—hematologic cancer	0.000236	0.0012	CcSEcCtD
Calcipotriol—Hypersensitivity—Hydroxyurea—hematologic cancer	0.000236	0.0012	CcSEcCtD
Calcipotriol—Rash—Imatinib—hematologic cancer	0.000235	0.0012	CcSEcCtD
Calcipotriol—Dermatitis—Imatinib—hematologic cancer	0.000235	0.0012	CcSEcCtD
Calcipotriol—Paraesthesia—Carmustine—hematologic cancer	0.000233	0.00118	CcSEcCtD
Calcipotriol—CYP24A1—Biological oxidations—GSTP1—hematologic cancer	0.000232	0.00176	CbGpPWpGaD
Calcipotriol—Rash—Cladribine—hematologic cancer	0.000231	0.00118	CcSEcCtD
Calcipotriol—MPO—IL23-mediated signaling events—PIK3CA—hematologic cancer	0.000231	0.00175	CbGpPWpGaD
Calcipotriol—Dermatitis—Cladribine—hematologic cancer	0.000231	0.00117	CcSEcCtD
Calcipotriol—Pain—Thalidomide—hematologic cancer	0.000231	0.00117	CcSEcCtD
Calcipotriol—VDR—Regulation of nuclear SMAD2/3 signaling—FOS—hematologic cancer	0.000231	0.00175	CbGpPWpGaD
Calcipotriol—Paraesthesia—Alitretinoin—hematologic cancer	0.000231	0.00117	CcSEcCtD
Calcipotriol—VDR—Regulation of nuclear SMAD2/3 signaling—CREB1—hematologic cancer	0.00023	0.00175	CbGpPWpGaD
Calcipotriol—MPO—Selenium Micronutrient Network—CCL2—hematologic cancer	0.00023	0.00175	CbGpPWpGaD
Calcipotriol—Pruritus—Lenalidomide—hematologic cancer	0.00023	0.00117	CcSEcCtD
Calcipotriol—CYP24A1—Metapathway biotransformation—GSTP1—hematologic cancer	0.000229	0.00174	CbGpPWpGaD
Calcipotriol—Paraesthesia—Ifosfamide—hematologic cancer	0.000228	0.00116	CcSEcCtD
Calcipotriol—VDR—Regulation of nuclear SMAD2/3 signaling—CREBBP—hematologic cancer	0.000224	0.0017	CbGpPWpGaD
Calcipotriol—Erythema—Triamcinolone—hematologic cancer	0.000223	0.00113	CcSEcCtD
Calcipotriol—Paraesthesia—Vincristine—hematologic cancer	0.000222	0.00113	CcSEcCtD
Calcipotriol—VDR—Validated transcriptional targets of TAp63 isoforms—CDKN1A—hematologic cancer	0.000222	0.00169	CbGpPWpGaD
Calcipotriol—Pain—Carmustine—hematologic cancer	0.000222	0.00113	CcSEcCtD
Calcipotriol—Hypersensitivity—Bortezomib—hematologic cancer	0.00022	0.00112	CcSEcCtD
Calcipotriol—MPO—Folate Metabolism—IL1B—hematologic cancer	0.00022	0.00167	CbGpPWpGaD
Calcipotriol—Pain—Alitretinoin—hematologic cancer	0.00022	0.00112	CcSEcCtD
Calcipotriol—MPO—Folate Metabolism—IL2—hematologic cancer	0.000219	0.00166	CbGpPWpGaD
Calcipotriol—Hypersensitivity—Bleomycin—hematologic cancer	0.000219	0.00111	CcSEcCtD
Calcipotriol—Pain—Ifosfamide—hematologic cancer	0.000217	0.0011	CcSEcCtD
Calcipotriol—Paraesthesia—Mitoxantrone—hematologic cancer	0.000216	0.0011	CcSEcCtD
Calcipotriol—Paraesthesia—Irinotecan—hematologic cancer	0.000216	0.0011	CcSEcCtD
Calcipotriol—Hypersensitivity—Vinorelbine—hematologic cancer	0.000215	0.0011	CcSEcCtD
Calcipotriol—MPO—Selenium Micronutrient Network—ALB—hematologic cancer	0.000215	0.00163	CbGpPWpGaD
Calcipotriol—CYP24A1—Biological oxidations—GSTM1—hematologic cancer	0.000213	0.00162	CbGpPWpGaD
Calcipotriol—Pruritus—Bortezomib—hematologic cancer	0.000212	0.00108	CcSEcCtD
Calcipotriol—Pain—Vincristine—hematologic cancer	0.000212	0.00108	CcSEcCtD
Calcipotriol—VDR—Validated transcriptional targets of TAp63 isoforms—EP300—hematologic cancer	0.000211	0.0016	CbGpPWpGaD
Calcipotriol—Rash—Melphalan—hematologic cancer	0.000211	0.00107	CcSEcCtD
Calcipotriol—Paraesthesia—Gemcitabine—hematologic cancer	0.000211	0.00107	CcSEcCtD
Calcipotriol—Dermatitis—Melphalan—hematologic cancer	0.000211	0.00107	CcSEcCtD
Calcipotriol—VDR—Direct p53 effectors—HGF—hematologic cancer	0.00021	0.0016	CbGpPWpGaD
Calcipotriol—Pruritus—Bleomycin—hematologic cancer	0.00021	0.00107	CcSEcCtD
Calcipotriol—CYP24A1—Metapathway biotransformation—GSTM1—hematologic cancer	0.00021	0.00159	CbGpPWpGaD
Calcipotriol—Dry skin—Epirubicin—hematologic cancer	0.00021	0.00107	CcSEcCtD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	0.000209	0.00159	CbGpPWpGaD
Calcipotriol—VDR—Generic Transcription Pathway—RARA—hematologic cancer	0.000209	0.00159	CbGpPWpGaD
Calcipotriol—MPO—C-MYB transcription factor network—CDKN2A—hematologic cancer	0.000208	0.00158	CbGpPWpGaD
Calcipotriol—Pruritus—Vinorelbine—hematologic cancer	0.000207	0.00105	CcSEcCtD
Calcipotriol—Pain—Irinotecan—hematologic cancer	0.000206	0.00105	CcSEcCtD
Calcipotriol—Pain—Mitoxantrone—hematologic cancer	0.000206	0.00105	CcSEcCtD
Calcipotriol—Hypersensitivity—Thiotepa—hematologic cancer	0.000206	0.00105	CcSEcCtD
Calcipotriol—MPO—C-MYB transcription factor network—BCL2—hematologic cancer	0.000205	0.00156	CbGpPWpGaD
Calcipotriol—Rash—Lenalidomide—hematologic cancer	0.000205	0.00104	CcSEcCtD
Calcipotriol—VDR—Direct p53 effectors—BAX—hematologic cancer	0.000205	0.00156	CbGpPWpGaD
Calcipotriol—Dermatitis—Lenalidomide—hematologic cancer	0.000205	0.00104	CcSEcCtD
Calcipotriol—MPO—IL23-mediated signaling events—IL6—hematologic cancer	0.000205	0.00155	CbGpPWpGaD
Calcipotriol—VDR—Retinoic acid receptors-mediated signaling—AKT1—hematologic cancer	0.000204	0.00155	CbGpPWpGaD
Calcipotriol—Rash—Hydroxyurea—hematologic cancer	0.000202	0.00103	CcSEcCtD
Calcipotriol—Erythema—Dexamethasone—hematologic cancer	0.000202	0.00103	CcSEcCtD
Calcipotriol—Erythema—Betamethasone—hematologic cancer	0.000202	0.00103	CcSEcCtD
Calcipotriol—Dermatitis—Hydroxyurea—hematologic cancer	0.000202	0.00103	CcSEcCtD
Calcipotriol—Pain—Gemcitabine—hematologic cancer	0.000201	0.00102	CcSEcCtD
Calcipotriol—Hypersensitivity—Thalidomide—hematologic cancer	0.000199	0.00101	CcSEcCtD
Calcipotriol—Pruritus—Thiotepa—hematologic cancer	0.000197	0.001	CcSEcCtD
Calcipotriol—Paraesthesia—Cisplatin—hematologic cancer	0.000196	0.001	CcSEcCtD
Calcipotriol—MPO—C-MYB transcription factor network—CD4—hematologic cancer	0.000196	0.00149	CbGpPWpGaD
Calcipotriol—MPO—Vitamin B12 Metabolism—TNF—hematologic cancer	0.000196	0.00149	CbGpPWpGaD
Calcipotriol—MPO—Selenium Micronutrient Network—IFNG—hematologic cancer	0.000196	0.00149	CbGpPWpGaD
Calcipotriol—VDR—Generic Transcription Pathway—NR0B2—hematologic cancer	0.000194	0.00147	CbGpPWpGaD
Calcipotriol—Dry skin—Doxorubicin—hematologic cancer	0.000194	0.000986	CcSEcCtD
Calcipotriol—VDR—Gene Expression—CASC3—hematologic cancer	0.000191	0.00145	CbGpPWpGaD
Calcipotriol—Hypersensitivity—Carmustine—hematologic cancer	0.000191	0.000972	CcSEcCtD
Calcipotriol—Pruritus—Thalidomide—hematologic cancer	0.000191	0.000971	CcSEcCtD
Calcipotriol—Hypersensitivity—Alitretinoin—hematologic cancer	0.000189	0.000962	CcSEcCtD
Calcipotriol—Rash—Bortezomib—hematologic cancer	0.000189	0.00096	CcSEcCtD
Calcipotriol—VDR—Direct p53 effectors—FAS—hematologic cancer	0.000189	0.00143	CbGpPWpGaD
Calcipotriol—Dermatitis—Bortezomib—hematologic cancer	0.000189	0.000959	CcSEcCtD
Calcipotriol—Rash—Bleomycin—hematologic cancer	0.000187	0.000953	CcSEcCtD
Calcipotriol—Pain—Cisplatin—hematologic cancer	0.000187	0.000952	CcSEcCtD
Calcipotriol—Dermatitis—Bleomycin—hematologic cancer	0.000187	0.000952	CcSEcCtD
Calcipotriol—Hypersensitivity—Ifosfamide—hematologic cancer	0.000187	0.000951	CcSEcCtD
Calcipotriol—MPO—C-MYB transcription factor network—CDKN1B—hematologic cancer	0.000185	0.0014	CbGpPWpGaD
Calcipotriol—Rash—Vinorelbine—hematologic cancer	0.000184	0.000937	CcSEcCtD
Calcipotriol—Dermatitis—Vinorelbine—hematologic cancer	0.000184	0.000936	CcSEcCtD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	0.000183	0.00139	CbGpPWpGaD
Calcipotriol—Hypersensitivity—Vincristine—hematologic cancer	0.000182	0.000927	CcSEcCtD
Calcipotriol—Pruritus—Alitretinoin—hematologic cancer	0.000182	0.000924	CcSEcCtD
Calcipotriol—Paraesthesia—Etoposide—hematologic cancer	0.00018	0.000916	CcSEcCtD
Calcipotriol—Pruritus—Ifosfamide—hematologic cancer	0.00018	0.000913	CcSEcCtD
Calcipotriol—VDR—Direct p53 effectors—BCL2L1—hematologic cancer	0.000178	0.00135	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—GMPS—hematologic cancer	0.000178	0.00135	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—FTCD—hematologic cancer	0.000178	0.00135	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—PHYH—hematologic cancer	0.000178	0.00135	CbGpPWpGaD
Calcipotriol—Hypersensitivity—Irinotecan—hematologic cancer	0.000178	0.000903	CcSEcCtD
Calcipotriol—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000178	0.000903	CcSEcCtD
Calcipotriol—Paraesthesia—Prednisolone—hematologic cancer	0.000178	0.000903	CcSEcCtD
Calcipotriol—VDR—Direct p53 effectors—TSC2—hematologic cancer	0.000177	0.00134	CbGpPWpGaD
Calcipotriol—Erythema—Prednisone—hematologic cancer	0.000176	0.000896	CcSEcCtD
Calcipotriol—MPO—C-MYB transcription factor network—CCND1—hematologic cancer	0.000176	0.00134	CbGpPWpGaD
Calcipotriol—Rash—Thiotepa—hematologic cancer	0.000176	0.000895	CcSEcCtD
Calcipotriol—Dermatitis—Thiotepa—hematologic cancer	0.000176	0.000894	CcSEcCtD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	0.000176	0.00133	CbGpPWpGaD
Calcipotriol—VDR—Generic Transcription Pathway—NCOR2—hematologic cancer	0.000175	0.00133	CbGpPWpGaD
Calcipotriol—MPO—Selenium Micronutrient Network—IL1B—hematologic cancer	0.000175	0.00133	CbGpPWpGaD
Calcipotriol—Pain—Etoposide—hematologic cancer	0.000171	0.000872	CcSEcCtD
Calcipotriol—MPO—C-MYB transcription factor network—CDKN1A—hematologic cancer	0.00017	0.00129	CbGpPWpGaD
Calcipotriol—Rash—Thalidomide—hematologic cancer	0.00017	0.000866	CcSEcCtD
Calcipotriol—Dermatitis—Thalidomide—hematologic cancer	0.00017	0.000865	CcSEcCtD
Calcipotriol—Pain—Prednisolone—hematologic cancer	0.000169	0.00086	CcSEcCtD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	0.000167	0.00127	CbGpPWpGaD
Calcipotriol—Pruritus—Gemcitabine—hematologic cancer	0.000166	0.000845	CcSEcCtD
Calcipotriol—VDR—Direct p53 effectors—MET—hematologic cancer	0.000166	0.00126	CbGpPWpGaD
Calcipotriol—VDR—Regulation of nuclear SMAD2/3 signaling—JUN—hematologic cancer	0.000166	0.00126	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	0.000166	0.00126	CbGpPWpGaD
Calcipotriol—Rash—Carmustine—hematologic cancer	0.000163	0.000831	CcSEcCtD
Calcipotriol—Dermatitis—Carmustine—hematologic cancer	0.000163	0.000831	CcSEcCtD
Calcipotriol—Paraesthesia—Triamcinolone—hematologic cancer	0.000163	0.000831	CcSEcCtD
Calcipotriol—CYP24A1—Metabolism—SMPD3—hematologic cancer	0.000162	0.00123	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	0.000162	0.00123	CbGpPWpGaD
Calcipotriol—MPO—C-MYB transcription factor network—EP300—hematologic cancer	0.000162	0.00123	CbGpPWpGaD
Calcipotriol—Rash—Alitretinoin—hematologic cancer	0.000162	0.000824	CcSEcCtD
Calcipotriol—Dermatitis—Alitretinoin—hematologic cancer	0.000162	0.000823	CcSEcCtD
Calcipotriol—Hypersensitivity—Cisplatin—hematologic cancer	0.000161	0.00082	CcSEcCtD
Calcipotriol—VDR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hematologic cancer	0.000161	0.00122	CbGpPWpGaD
Calcipotriol—Rash—Ifosfamide—hematologic cancer	0.00016	0.000814	CcSEcCtD
Calcipotriol—Dermatitis—Ifosfamide—hematologic cancer	0.00016	0.000813	CcSEcCtD
Calcipotriol—MPO—Folate Metabolism—TNF—hematologic cancer	0.00016	0.00121	CbGpPWpGaD
Calcipotriol—MPO—Vitamin B12 Metabolism—IL6—hematologic cancer	0.000158	0.0012	CbGpPWpGaD
Calcipotriol—Rash—Vincristine—hematologic cancer	0.000156	0.000794	CcSEcCtD
Calcipotriol—Dermatitis—Vincristine—hematologic cancer	0.000156	0.000793	CcSEcCtD
Calcipotriol—Pain—Triamcinolone—hematologic cancer	0.000155	0.000791	CcSEcCtD
Calcipotriol—VDR—Regulation of nuclear SMAD2/3 signaling—EP300—hematologic cancer	0.000153	0.00116	CbGpPWpGaD
Calcipotriol—Rash—Mitoxantrone—hematologic cancer	0.000152	0.000773	CcSEcCtD
Calcipotriol—Rash—Irinotecan—hematologic cancer	0.000152	0.000773	CcSEcCtD
Calcipotriol—Dermatitis—Mitoxantrone—hematologic cancer	0.000152	0.000772	CcSEcCtD
Calcipotriol—Dermatitis—Irinotecan—hematologic cancer	0.000152	0.000772	CcSEcCtD
Calcipotriol—MPO—C-MYB transcription factor network—NRAS—hematologic cancer	0.000152	0.00115	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	0.000151	0.00115	CbGpPWpGaD
Calcipotriol—Paraesthesia—Betamethasone—hematologic cancer	0.000148	0.000754	CcSEcCtD
Calcipotriol—Paraesthesia—Dexamethasone—hematologic cancer	0.000148	0.000754	CcSEcCtD
Calcipotriol—Rash—Gemcitabine—hematologic cancer	0.000148	0.000753	CcSEcCtD
Calcipotriol—Dermatitis—Gemcitabine—hematologic cancer	0.000148	0.000752	CcSEcCtD
Calcipotriol—Hypersensitivity—Etoposide—hematologic cancer	0.000148	0.000751	CcSEcCtD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	0.000148	0.00112	CbGpPWpGaD
Calcipotriol—Erythema—Methotrexate—hematologic cancer	0.000147	0.000748	CcSEcCtD
Calcipotriol—Hypersensitivity—Prednisolone—hematologic cancer	0.000146	0.000741	CcSEcCtD
Calcipotriol—VDR—Direct p53 effectors—CREBBP—hematologic cancer	0.000145	0.0011	CbGpPWpGaD
Calcipotriol—VDR—Direct p53 effectors—RB1—hematologic cancer	0.000144	0.0011	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—B3GAT1—hematologic cancer	0.000142	0.00108	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—ASNS—hematologic cancer	0.000142	0.00108	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—DCK—hematologic cancer	0.000142	0.00108	CbGpPWpGaD
Calcipotriol—Pruritus—Etoposide—hematologic cancer	0.000142	0.000721	CcSEcCtD
Calcipotriol—MPO—C-MYB transcription factor network—MYC—hematologic cancer	0.000141	0.00107	CbGpPWpGaD
Calcipotriol—Pain—Betamethasone—hematologic cancer	0.000141	0.000718	CcSEcCtD
Calcipotriol—Pain—Dexamethasone—hematologic cancer	0.000141	0.000718	CcSEcCtD
Calcipotriol—MPO—Folate Metabolism—TP53—hematologic cancer	0.000141	0.00107	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	0.000139	0.00105	CbGpPWpGaD
Calcipotriol—Rash—Cisplatin—hematologic cancer	0.000138	0.000702	CcSEcCtD
Calcipotriol—Dermatitis—Cisplatin—hematologic cancer	0.000138	0.000701	CcSEcCtD
Calcipotriol—Erythema—Epirubicin—hematologic cancer	0.000138	0.0007	CcSEcCtD
Calcipotriol—CYP24A1—Metabolism—HDC—hematologic cancer	0.000135	0.00102	CbGpPWpGaD
Calcipotriol—Hypersensitivity—Triamcinolone—hematologic cancer	0.000134	0.000681	CcSEcCtD
Calcipotriol—VDR—Regulation of nuclear SMAD2/3 signaling—MYC—hematologic cancer	0.000133	0.00101	CbGpPWpGaD
Calcipotriol—MPO—C-MYB transcription factor network—KRAS—hematologic cancer	0.00013	0.00099	CbGpPWpGaD
Calcipotriol—Paraesthesia—Prednisone—hematologic cancer	0.000129	0.000656	CcSEcCtD
Calcipotriol—MPO—Folate Metabolism—IL6—hematologic cancer	0.000129	0.000977	CbGpPWpGaD
Calcipotriol—Pruritus—Triamcinolone—hematologic cancer	0.000129	0.000654	CcSEcCtD
Calcipotriol—Erythema—Doxorubicin—hematologic cancer	0.000127	0.000648	CcSEcCtD
Calcipotriol—MPO—Selenium Micronutrient Network—TNF—hematologic cancer	0.000127	0.000962	CbGpPWpGaD
Calcipotriol—Rash—Etoposide—hematologic cancer	0.000126	0.000643	CcSEcCtD
Calcipotriol—Dermatitis—Etoposide—hematologic cancer	0.000126	0.000642	CcSEcCtD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	0.000125	0.000953	CbGpPWpGaD
Calcipotriol—VDR—Direct p53 effectors—BCL2—hematologic cancer	0.000125	0.000948	CbGpPWpGaD
Calcipotriol—Rash—Prednisolone—hematologic cancer	0.000125	0.000634	CcSEcCtD
Calcipotriol—Dermatitis—Prednisolone—hematologic cancer	0.000125	0.000634	CcSEcCtD
Calcipotriol—VDR—Gene Expression—RARS—hematologic cancer	0.000123	0.000936	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—CDA—hematologic cancer	0.000123	0.000934	CbGpPWpGaD
Calcipotriol—VDR—Direct p53 effectors—MDM2—hematologic cancer	0.000123	0.000934	CbGpPWpGaD
Calcipotriol—Ergocalciferol—AR—hematologic cancer	0.000121	1	CrCbGaD
Calcipotriol—CYP24A1—Metabolism—PC—hematologic cancer	0.000118	0.000899	CbGpPWpGaD
Calcipotriol—Pruritus—Dexamethasone—hematologic cancer	0.000117	0.000594	CcSEcCtD
Calcipotriol—Pruritus—Betamethasone—hematologic cancer	0.000117	0.000594	CcSEcCtD
Calcipotriol—VDR—Gene Expression—POLR3E—hematologic cancer	0.000116	0.00088	CbGpPWpGaD
Calcipotriol—Rash—Triamcinolone—hematologic cancer	0.000115	0.000583	CcSEcCtD
Calcipotriol—Dermatitis—Triamcinolone—hematologic cancer	0.000115	0.000583	CcSEcCtD
Calcipotriol—CYP24A1—Metabolism—SLC35B2—hematologic cancer	0.000114	0.000869	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—GBA—hematologic cancer	0.000114	0.000869	CbGpPWpGaD
Calcipotriol—VDR—Generic Transcription Pathway—PARP1—hematologic cancer	0.000111	0.000846	CbGpPWpGaD
Calcipotriol—MPO—C-MYB transcription factor network—HRAS—hematologic cancer	0.000111	0.000842	CbGpPWpGaD
Calcipotriol—Paraesthesia—Methotrexate—hematologic cancer	0.000108	0.000548	CcSEcCtD
Calcipotriol—VDR—Direct p53 effectors—JUN—hematologic cancer	0.000107	0.000812	CbGpPWpGaD
Calcipotriol—Hypersensitivity—Prednisone—hematologic cancer	0.000106	0.000538	CcSEcCtD
Calcipotriol—CYP24A1—Metabolism—MTAP—hematologic cancer	0.000105	0.000795	CbGpPWpGaD
Calcipotriol—Rash—Dexamethasone—hematologic cancer	0.000104	0.000529	CcSEcCtD
Calcipotriol—Rash—Betamethasone—hematologic cancer	0.000104	0.000529	CcSEcCtD
Calcipotriol—Dermatitis—Dexamethasone—hematologic cancer	0.000104	0.000529	CcSEcCtD
Calcipotriol—Dermatitis—Betamethasone—hematologic cancer	0.000104	0.000529	CcSEcCtD
Calcipotriol—VDR—Direct p53 effectors—CDKN1A—hematologic cancer	0.000104	0.000787	CbGpPWpGaD
Calcipotriol—VDR—Direct p53 effectors—PTEN—hematologic cancer	0.000103	0.000785	CbGpPWpGaD
Calcipotriol—Pain—Methotrexate—hematologic cancer	0.000103	0.000522	CcSEcCtD
Calcipotriol—MPO—Selenium Micronutrient Network—IL6—hematologic cancer	0.000102	0.000776	CbGpPWpGaD
Calcipotriol—Pruritus—Prednisone—hematologic cancer	0.000102	0.000517	CcSEcCtD
Calcipotriol—Paraesthesia—Epirubicin—hematologic cancer	0.000101	0.000513	CcSEcCtD
Calcipotriol—VDR—Gene Expression—RARA—hematologic cancer	0.000101	0.000763	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—TET2—hematologic cancer	0.000101	0.000763	CbGpPWpGaD
Calcipotriol—VDR—Direct p53 effectors—EP300—hematologic cancer	9.87e-05	0.000749	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—RPLP1—hematologic cancer	9.86e-05	0.000748	CbGpPWpGaD
Calcipotriol—Pain—Epirubicin—hematologic cancer	9.61e-05	0.000489	CcSEcCtD
Calcipotriol—VDR—Gene Expression—NR0B2—hematologic cancer	9.35e-05	0.00071	CbGpPWpGaD
Calcipotriol—Paraesthesia—Doxorubicin—hematologic cancer	9.34e-05	0.000475	CcSEcCtD
Calcipotriol—CYP24A1—Metabolism—FHL2—hematologic cancer	9.33e-05	0.000708	CbGpPWpGaD
Calcipotriol—VDR—Generic Transcription Pathway—AR—hematologic cancer	9.33e-05	0.000708	CbGpPWpGaD
Calcipotriol—VDR—Regulation of nuclear SMAD2/3 signaling—AKT1—hematologic cancer	9.24e-05	0.000701	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—AGRN—hematologic cancer	9.15e-05	0.000694	CbGpPWpGaD
Calcipotriol—Rash—Prednisone—hematologic cancer	9.06e-05	0.000461	CcSEcCtD
Calcipotriol—Dermatitis—Prednisone—hematologic cancer	9.05e-05	0.00046	CcSEcCtD
Calcipotriol—VDR—Gene Expression—DNMT3A—hematologic cancer	8.92e-05	0.000677	CbGpPWpGaD
Calcipotriol—Pain—Doxorubicin—hematologic cancer	8.89e-05	0.000452	CcSEcCtD
Calcipotriol—Hypersensitivity—Methotrexate—hematologic cancer	8.85e-05	0.00045	CcSEcCtD
Calcipotriol—VDR—Gene Expression—ELL—hematologic cancer	8.79e-05	0.000667	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—HMMR—hematologic cancer	8.67e-05	0.000658	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—IDH2—hematologic cancer	8.67e-05	0.000658	CbGpPWpGaD
Calcipotriol—VDR—Generic Transcription Pathway—CDKN2B—hematologic cancer	8.59e-05	0.000652	CbGpPWpGaD
Calcipotriol—Pruritus—Methotrexate—hematologic cancer	8.49e-05	0.000432	CcSEcCtD
Calcipotriol—VDR—Gene Expression—NCOR2—hematologic cancer	8.44e-05	0.00064	CbGpPWpGaD
Calcipotriol—Hypersensitivity—Epirubicin—hematologic cancer	8.28e-05	0.000421	CcSEcCtD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	8.18e-05	0.000621	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—ARNTL—hematologic cancer	8.15e-05	0.000619	CbGpPWpGaD
Calcipotriol—VDR—Generic Transcription Pathway—NCOR1—hematologic cancer	8.15e-05	0.000619	CbGpPWpGaD
Calcipotriol—Pruritus—Epirubicin—hematologic cancer	7.95e-05	0.000404	CcSEcCtD
Calcipotriol—CYP24A1—Metabolism—CA9—hematologic cancer	7.93e-05	0.000602	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—ACP5—hematologic cancer	7.93e-05	0.000602	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—NCOR2—hematologic cancer	7.83e-05	0.000594	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—AGO2—hematologic cancer	7.78e-05	0.00059	CbGpPWpGaD
Calcipotriol—Hypersensitivity—Doxorubicin—hematologic cancer	7.66e-05	0.00039	CcSEcCtD
Calcipotriol—VDR—Gene Expression—DNMT3B—hematologic cancer	7.62e-05	0.000578	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—H3F3B—hematologic cancer	7.62e-05	0.000578	CbGpPWpGaD
Calcipotriol—Rash—Methotrexate—hematologic cancer	7.57e-05	0.000385	CcSEcCtD
Calcipotriol—Dermatitis—Methotrexate—hematologic cancer	7.56e-05	0.000385	CcSEcCtD
Calcipotriol—VDR—Generic Transcription Pathway—NR3C1—hematologic cancer	7.54e-05	0.000573	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—IDH1—hematologic cancer	7.46e-05	0.000566	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—TXN—hematologic cancer	7.37e-05	0.00056	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—ABCC3—hematologic cancer	7.37e-05	0.00056	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—GSTO1—hematologic cancer	7.37e-05	0.00056	CbGpPWpGaD
Calcipotriol—Pruritus—Doxorubicin—hematologic cancer	7.36e-05	0.000374	CcSEcCtD
Calcipotriol—CYP24A1—Metabolism—SPHK1—hematologic cancer	7.22e-05	0.000548	CbGpPWpGaD
Calcipotriol—Rash—Epirubicin—hematologic cancer	7.08e-05	0.00036	CcSEcCtD
Calcipotriol—Dermatitis—Epirubicin—hematologic cancer	7.08e-05	0.00036	CcSEcCtD
Calcipotriol—VDR—Direct p53 effectors—TP53—hematologic cancer	7.06e-05	0.000536	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—RPS14—hematologic cancer	6.97e-05	0.000529	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—UGT1A1—hematologic cancer	6.93e-05	0.000526	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—NUP98—hematologic cancer	6.86e-05	0.000521	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—CRABP1—hematologic cancer	6.74e-05	0.000512	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—SLC22A1—hematologic cancer	6.74e-05	0.000512	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—NUP214—hematologic cancer	6.61e-05	0.000502	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—ALOX5—hematologic cancer	6.57e-05	0.000499	CbGpPWpGaD
Calcipotriol—Rash—Doxorubicin—hematologic cancer	6.56e-05	0.000333	CcSEcCtD
Calcipotriol—Dermatitis—Doxorubicin—hematologic cancer	6.55e-05	0.000333	CcSEcCtD
Calcipotriol—VDR—Generic Transcription Pathway—ESR1—hematologic cancer	6.4e-05	0.000486	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—NUP98—hematologic cancer	6.37e-05	0.000483	CbGpPWpGaD
Calcipotriol—VDR—Generic Transcription Pathway—NOTCH1—hematologic cancer	6.19e-05	0.00047	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—ADCY7—hematologic cancer	6.18e-05	0.000469	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—NCOA3—hematologic cancer	6.18e-05	0.000469	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—NUP214—hematologic cancer	6.14e-05	0.000466	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—HSPB1—hematologic cancer	6.09e-05	0.000462	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—EIF4EBP1—hematologic cancer	6.09e-05	0.000462	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.07e-05	0.000461	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—ABCG2—hematologic cancer	6.01e-05	0.000456	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—MTR—hematologic cancer	6.01e-05	0.000456	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—ENO2—hematologic cancer	5.9e-05	0.000448	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—SMC1A—hematologic cancer	5.83e-05	0.000443	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—GSTT1—hematologic cancer	5.72e-05	0.000434	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—H3F3A—hematologic cancer	5.72e-05	0.000434	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.63e-05	0.000427	CbGpPWpGaD
Calcipotriol—VDR—Generic Transcription Pathway—CREBBP—hematologic cancer	5.61e-05	0.000426	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—SDC1—hematologic cancer	5.59e-05	0.000424	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—EZH2—hematologic cancer	5.48e-05	0.000416	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—PARP1—hematologic cancer	5.37e-05	0.000408	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.34e-05	0.000405	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.27e-05	0.0004	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—HDAC2—hematologic cancer	5.18e-05	0.000393	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.04e-05	0.000383	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—CD44—hematologic cancer	4.75e-05	0.000361	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—NQO1—hematologic cancer	4.75e-05	0.000361	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.65e-05	0.000353	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—CYCS—hematologic cancer	4.5e-05	0.000341	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—AR—hematologic cancer	4.49e-05	0.000341	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—HSP90AA1—hematologic cancer	4.47e-05	0.000339	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—CDKN2B—hematologic cancer	4.14e-05	0.000314	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.02e-05	0.000305	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—GSTP1—hematologic cancer	3.96e-05	0.000301	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—NCOR1—hematologic cancer	3.92e-05	0.000298	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.83e-05	0.000291	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—ABCB1—hematologic cancer	3.75e-05	0.000285	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—NCOR1—hematologic cancer	3.64e-05	0.000276	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—GSTM1—hematologic cancer	3.64e-05	0.000276	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—NR3C1—hematologic cancer	3.63e-05	0.000276	CbGpPWpGaD
Calcipotriol—VDR—Generic Transcription Pathway—MYC—hematologic cancer	3.33e-05	0.000253	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—MTHFR—hematologic cancer	3.22e-05	0.000244	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—MAPK14—hematologic cancer	3.14e-05	0.000239	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—ESR1—hematologic cancer	3.08e-05	0.000234	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—NOTCH1—hematologic cancer	2.98e-05	0.000226	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.84e-05	0.000215	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—PIK3CG—hematologic cancer	2.7e-05	0.000205	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—CREBBP—hematologic cancer	2.7e-05	0.000205	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—CREBBP—hematologic cancer	2.51e-05	0.00019	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—PIK3CD—hematologic cancer	2.38e-05	0.00018	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—ALB—hematologic cancer	2.35e-05	0.000178	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—PIK3R1—hematologic cancer	2.24e-05	0.00017	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—PIK3CB—hematologic cancer	2.07e-05	0.000157	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—PTEN—hematologic cancer	1.79e-05	0.000136	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—EP300—hematologic cancer	1.71e-05	0.00013	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—MAPK3—hematologic cancer	1.65e-05	0.000125	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—MYC—hematologic cancer	1.6e-05	0.000122	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—PIK3CA—hematologic cancer	1.26e-05	9.59e-05	CbGpPWpGaD
Calcipotriol—VDR—Gene Expression—AKT1—hematologic cancer	1.11e-05	8.44e-05	CbGpPWpGaD
Calcipotriol—CYP24A1—Metabolism—AKT1—hematologic cancer	1.03e-05	7.83e-05	CbGpPWpGaD
